Trial Profile
The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder; Major depressive disorder; Panic disorder; Social phobia
- Focus Pharmacodynamics
- Acronyms Cipralex&GBM
- 09 Dec 2015 New trial record